Search Within

Iman Osman

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (10)
  2. Sloan Kettering Institute Faculty (10)
  3. Department of Medicine (7)
  4. GSK Faculty (7)
  5. Genitourinary Oncology Service (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Homer Macapinlac (5)
  2. Howard Scher (5)
  3. Steven Larson (5)
  4. Timothy Akhurst (5)
  5. Henry Yeung (4)
  6. Maria Dudas (3)

More People

Years
  1. 2011 (2)
  2. 2006 (2)
  3. 2005 (1)
  4. 2002 (2)
  5. 1999 (2)
  6. 1998 (1)
Publications
  1. Journal of Nuclear Medicine (2)
  2. Cancer Research (1)
  3. Clinical Positron Imaging (1)
  4. European Journal of Nuclear Medicine (1)
  5. Histology and Histopathology (1)
  6. Laboratory Investigation (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. Society of Nuclear Medicine (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. Nature Research (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of immunohistochemistry with FISH for detection of TMPRSS2-ERG rearrangement in prostate cancers in African American and Caucasian populations
    Meeting Abstract

    Elliott, R. M.; Leversha, M. A.; Satagopan, J. M.; Zhou, Q. C.; Dudas, M.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; Tickoo, S.; Eastham, J. A.; more...
    Modern Pathology (2011)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry with FISH for detection of TMPRSS2-ERG rearrangement in prostate cancers in African American and Caucasian populations
    Meeting Abstract

    Elliott, R. M.; Leversha, M. A.; Satagopan, J. M.; Zhou, Q.; Dudas, M.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; Tickoo, S.; Eastham, J. A.; more...
    Laboratory Investigation (2011)

    Fulltext@MSK | Save
  • BRAF mutation predicts sensitivity to MEK inhibition
    Journal Article

    Solit, D. B.; Garraway, L. A.; Pratilas, C. A.; Sawai, A.; Getz, G.; Basso, A.; Ye, Q.; Lobo, J. M.; She, Y.; Osman, I.; more...
    Nature (2006)

    Fulltext@MSK | Save
  • Altered patterns of RB expression define groups of soft tissue sarcoma patients with distinct biological and clinical behavior
    Journal Article

    Polsky, D.; Mastorides, M.; Kim, D.; Dudas, M.; Leon, L.; Leung, D.; Woodruff, J. M.; Brennan, M. F.; Osman, I.; Cordon-Cardo, C.
    Histology and Histopathology (2006)

    Fulltext@MSK | Save
  • Treatment of melanoma patients with 17AAG results in downregulation of the MAPK pathway in the melanoma tumors
    Meeting Abstract

    Friedlander, P.; Solit, D.; Osman, I.; Polsky, D.; Elamparo, R.; Rosen, N.; Chapman, P. B.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Combined (18)F-FDG and (11)C-methionine PET scans in patients with newly progressive metastatic prostate cancer
    Journal Article

    Nunez, R.; Macapinlac, H. A.; Yeung, H. W. D.; Akhurst, T.; Cai, S. D.; Osman, I.; Gonen, M.; Riedel, E.; Scher, H. I.; Larson, S. M.
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save
  • Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer
    Journal Article

    Morris, M. J.; Akhurst, T.; Osman, I.; Nunez, R.; Macapinlac, H.; Siedlecki, K.; Verbel, D.; Schwartz, L.; Larson, S. M.; Scher, H. I.
    Urology (2002)

    Fulltext@MSK | Save
  • [F-18]2-fluoro-2-doxyglucose (FDG) and C-11-methionine (C-11 MET) positron emission tomography (PET) versus conventional imaging modalities (CIM) in patients with newly progressing metastatic prostate cancer
    Meeting Abstract

    Nunez, R.; Macapinlac, H.; Yeung, H. W. D.; Akhurst, T.; Finn, R. D.; Osman, I.; Petrisko, R.; Scher, H. I.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Differential metabolism and pharmacokinetics of L-[1-(11)C]-methionine and 2-[(18)F] fluoro-2-deoxy-D-glucose (FDG) in androgen independent prostate cancer
    Journal Article

    Macapinlac, H. A.; Humm, J. L.; Akhurst, T.; Osman, I.; Pentlow, K.; Cai, S.; Yeung, H. W. D.; Squire, O.; Finn, R. D.; Scher, H. I.; more...
    Clinical Positron Imaging (1999)

    Fulltext@MSK | Save
  • Differential metabolism and pharmacokinetics of C-11 methionine (C11-MET) and FDG in metastatic prostate cancer
    Meeting Abstract

    Macapinlac, H. A.; Humm, J. L.; Larson, S. M.; Akhurst, T.; Squire, O. D.; Pentlow, K.; Yeung, H. W. D.; Finn, R. D.; Cai, S.; Osman, I.; more...
    Journal of Nuclear Medicine (1998)

    Fulltext@MSK | Save